DMAC CIK: 1401040

DiaMedica Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.6
FY22:
−14.0
FY23:
−21.3
FY24:
−26.7
FY25:
−34.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.6
FY22:
−14.0
FY23:
−21.2
FY24:
−26.6
FY25:
−34.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.6
FY22:
−13.6
FY23:
−19.3
FY24:
−24.4
FY25:
−32.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.6
FY22:
−13.7
FY23:
−19.4
FY24:
−24.4
FY25:
−32.8

All amounts in millions USD Data sources:SEC EDGARTwelve Data